Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Immucell (ICCC) posted Return on Capital Employed [ROCE] of 11.27% for Q3 2026, up 5.23 percentage points from 6.04% a year earlier and up 1.83 percentage points from the prior quarter.

Analysis

Immucell (ICCC) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Immucell's Return on Capital Employed [ROCE] came in at 4.14%, up 8.24 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +7.84 percentage points (FY2020 to FY2025).
  • In prior years, Immucell's Return on Capital Employed [ROCE] was -4.10% in FY2024 (+10.23 pp), -14.32% in FY2023 (-8.79 pp), -5.53% in FY2022 (-6.17 pp) and 0.65% in FY2021 (+4.35 pp).
  • The Q3 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2016.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last 11 quarters, with an average year-over-year change of +7.97 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2025, with a gain of 11.95 percentage points; the weakest was Q2 2023, with a drop of 15.60 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 9.45% (Q2 2026), 6.35% (Q1 2026) and 4.28% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 11.27%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.27%
Jun 30, 2026 9.45%
Mar 31, 2026 6.35%
Dec 31, 2025 4.11%
Sep 30, 2025 5.80%
Jun 30, 2025 4.37%
Mar 31, 2025 -0.54%
Dec 31, 2024 -4.06%
Sep 30, 2024 -5.85%
Jun 30, 2024 -7.58%
Mar 31, 2024 -7.11%
Dec 31, 2023 -11.87%
Sep 30, 2023 -15.58%
Jun 30, 2023 -14.76%
Mar 31, 2023 -12.76%
Dec 31, 2022 -5.40%
Sep 30, 2022 -1.20%
Jun 30, 2022 0.84%
Mar 31, 2022 2.80%
Dec 31, 2021 0.62%
API Access

Immucell Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY